Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pfizer (NY: PFE ) 28.90 +0.12 (+0.42%) Official Closing Price Updated: 7:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pfizer < Previous 1 2 ... 5 6 7 8 9 10 11 12 13 ... 99 100 Next > 10 Health Care Stocks Whale Activity In Today's Session June 26, 2024 Via Benzinga Why Is Moderna Stock Trading Lower On Wednesday? June 26, 2024 The CDC's Advisory Committee on Immunization Practices is set to discuss recommendations for RSV, influenza, and COVID-19 vaccines. Moderna's data shows vaccine efficacy drops to 50% after 18 months in... Via Benzinga Exposures COVID-19 Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots June 26, 2024 After 18 months, Moderna's RSV vaccine proved about 50% effective against lower respiratory tract disease. Via Investor's Business Daily Is Pfizer's Pain Sarepta Therapeutics' Gain? Don't Bet on It. June 26, 2024 One company's negative results can increase scrutiny of another's work. Via The Motley Fool 3 Blue-Chip Stocks to Buy on the Dip: June 2024 June 26, 2024 These top blue-chip stocks to buy on the dipare proven winners offering solid long-term growth, reliable dividends and excellent value. Via InvestorPlace A patient’s story: Managing ulcerative colitis symptoms from diagnosis to treatment June 24, 2024 (BPT) - Content sponsored and provided by Pfizer. Tiffany partnered with Pfizer to share her experience living with moderate to severe ulcerative colitis (UC). Via Brandpoint 10 Health Care Stocks Whale Activity In Today's Session June 25, 2024 Via Benzinga Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk? June 25, 2024 This is a matchup that the latecomer might not be able to win. Via The Motley Fool 5 Dividend Stocks Yielding at Least 5% to Buy Right Now for Passive Income June 25, 2024 These companies pay well above average dividends. Via The Motley Fool Forget Nvidia: Prominent Billionaires Are Selling It in Favor of These 7 Top-Notch Stocks June 25, 2024 More than a half-dozen of Wall Street's most-successful billionaire investors dumped shares of Nvidia during the March-ended quarter and made these seven stocks their top buys. Via The Motley Fool 3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains June 24, 2024 These are the undervalued pharma stocks and represent companies with a deep research pipeline, that provides sustained growth visibility. Via InvestorPlace Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case June 24, 2024 The U.S. Supreme Court supports pharmaceutical companies, led by AstraZeneca, in a lawsuit accusing them of funding terrorism in Iraq, dismissing a lower court's ruling and sending the case back for... Via Benzinga Topics Lawsuit Exposures Financial Legal UK Chooses Pfizer Over GSK for Multi-Million Dose RSV Vaccine Contract June 24, 2024 Pfizer secures a UK contract to supply millions of doses of its Abrysvo RSV vaccine, surpassing GSK's bid. The agreement includes doses for older adults and pregnant mothers. Via Benzinga Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success June 24, 2024 The challenge for Alnylam now will be to find and diagnose patients with the condition known as ATTR-CM, which is considered rare. Via InvestorPlace Alnylam Skyrockets After Hitting A 'Best-Case Scenario' For Heart Drug June 24, 2024 The companies are working on treatments for ATTR amyloidosis with cardiomyopathy. Via Investor's Business Daily 2 Beaten-Down Growth Stocks to Buy Without Hesitation in the 2024 Bull Market June 24, 2024 Price only tells you part of the story. Via The Motley Fool 7 Dividend Stocks to Buy Now: June 2024 June 23, 2024 These dividend stocks to buy now will reward investors with income now and growth as the market breadth expands. Via InvestorPlace Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks June 23, 2024 It doesn't take much to boost your passive income stream with these top dividend-paying stocks. Via The Motley Fool 3 No-Brainer Stocks to Buy for Under $100 Right Now June 22, 2024 You won't need much money to start investing in these great stocks. Via The Motley Fool 3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold June 22, 2024 The pharmaceutical industry giants offer reliable profit growth and above-average dividend yields. Via The Motley Fool Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments June 21, 2024 Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments. Via Benzinga FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy June 21, 2024 The FDA has approved Sarepta Therapeutics' Elevidys for treating Duchenne muscular dystrophy in patients aged 4 and older with specific DMD gene mutations. Via Benzinga Exposures Product Safety Sarepta Skyrockets After Nabbing A Broad Label For Its Duchenne Gene Therapy June 20, 2024 The agency signed off on Elevidys for a broad population of children with the muscle-wasting disease. Via Investor's Business Daily Industry Groups Back GSK's Effort To Halt 70,000 Lawsuits Associated With Heartburn Drug Zantac Caused Cancer June 20, 2024 GSK, supported by major industry groups, seeks to stop 70,000 Zantac lawsuits in Delaware, arguing a recent court ruling threatens the state's business-friendly reputation and judicial consistency. Via Benzinga Topics Lawsuit Exposures Financial Legal Skip Meme Mania: 3 Undervalued Blue-Chip Stocks for Steady Returns June 20, 2024 These are the undervalued blue-chip stocks to buy, as they represent companies with strong fundamentals and robust cash flow outlooks. Via InvestorPlace Supreme Court Upholds 2017 Tax On Foreign Profits For US Businesses June 20, 2024 US Supreme Court upholds 2017 tax on foreign business income, citing Congress' constitutional power to tax. Justices Kavanaugh, Thomas, and Gorsuch dissented. Via Benzinga 3 Underrated Dividend Stock Machines to Turbocharge Your Income June 20, 2024 If you are a passive income investor, take a look at these underrated dividend stocks to buy for steady income. Via InvestorPlace 7 High-Value Blue-Chip Stocks to Boost Your Wealth by 2027 June 20, 2024 Discover these blue-chip stocks to buy in the biotechnology, banking, pharmaceuticals, tobacco, restaurants, and entertainment industries. Via InvestorPlace Palantir, Oracle, Pfizer Chiefs Lobby US Lawmakers For Israel's Support Amid Hamas Attack, Hostage Crisis June 19, 2024 CEOs of Palantir, Oracle, and Pfizer lobbied US senators for support of Israel during Gaza invasion and discussed solutions for hostages held by Hamas. Via Benzinga Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment June 18, 2024 AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a... Via Benzinga Exposures COVID-19 < Previous 1 2 ... 5 6 7 8 9 10 11 12 13 ... 99 100 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.